SUMMARY While an association between blood eosinophilia and endomyocardial disease has been recognized, the role of the eosinophil in the pathogenesis of the cardiac lesions remains uncertain. In a 69-year-old man with large cell carcinoma of the lung, marked eosinophilia was stimulated by and progressed with the course of the neoplasm which was producing an eosinophil chemotactic factor. Peripheral blood eosinophils were vacuolated and degranulated while those in the bone marrow were morphologically SINCE 1893, when Reinbach first described a right ventricular endocardial mural thrombus in a patient with eosinophilia,1 the association between blood eosinophilia and endomyocardial disease has been recognized in various clinical entities including Loffler's endocarditis parietalis fibroplastica,2 Davies' African endomyocardial fibrosis,3 eosinophilic leukemia,4 and eosinophilic collagen disease. 5 Although the two latter conditions are characterized by widespread eosinophil infiltration of other tissues in addition to the heart and lung, it has been suggested that all of these diseases are representative of a continuum.' 7 Peripheral blood and bone marrow eosinophils from patients with hypereosinophilic disease manifesting cardiac and other tissue infiltration have shown a degree of degranulation and vacuolization greater than normal subjects or patients with transient eosinophilia.8 9 Labelled autologous eosinophils in such patients disappear from the circulation more slowly than normal cells, after an initial phase of rapid clearance and reappearance, which suggests transient entry into tissue spaces.10 Presumably, massive infiltration of the heart with eosinophils is associated with cardiac dysfunction. In patients with cardiac disease, however, no direct causative role for the eosinophil in the pathogenesis of the cardiac lesions has been established.
Our finding of endomyocardial disease in a patient with chronic peripheral blood eosinophilia and eosinophil infiltration of pulmonary and cardiac tissues secondary to a bronchogenic tumor indicates that profound eosinophilia of diverse causes may be associated with endomyocardial disease. An apparently unique 300-400 molecular weight peptide eosinophil chemotactic factor was recognized in tumor thought to be due to pericardial metastases and/or myocardial disease. The lung mass and associated pulmonary infiltrates and pleural effusion precluded accurate radiologic assessment of heart size. On December 22, 1975, 12 months after onset of symptoms, the patient died of respiratory failure.
Anatomical Findings In the lung there was a 7 cm mass originating in the right main bronchus which extended into the lung parenchyma, diaphragm, and parietal pericardium. Microscopically, the tumor was composed of very large pleomorphic cells with FIGURE 2. Beneath the mural thrombus (T), the endocardium (E) is thickened by collagenous tissue which extends into the underlying myocardium. (Trichrome, X 40.) bizarre, hyperchromatic, and sometimes multiple nuclei containing prominent nucleoli. Mitoses were common. The main tumor mass was surrounded by a cellular infiltrate composed mainly of eosinophils which had reduced numbers of cytoplasmic granules. Areas of bronchopneumonia also were present in the lung.
The heart weighed 420 g and was free of direct involvement by tumor. The left ventricular cavity contained an apical mural thrombus, 4 cm in diameter, superimposed on a thickened endocardium ( fig. l) . Other similar but smaller thrombi were present in the right and left ventricles. Microscopically, there was organization of the thrombi by connective tissue proliferating from the endocardium. The connective tissue, which contained very few elastic fibers, also extended into adjacent myocardium where areas of interstitial and replacement fibrosis were present ( fig. 2 ). There were cellular infiltrates in the myocardium composed almost entirely of eosinophils ( fig. 3 ) with reduced numbers of cytoplasmic granules adjacent to areas of fibrosis. Focal areas of myocardial necrosis were also present and infiltrated by eosinophils (fig. 4) subendocardial myocardium adjacent to areas with overlying endocardial fibrosis and mural thrombi. The extra and intramural coronary arteries and cardiac valves were normal.
Infiltrates of eosinophils were present in the sinusoids of the liver and spleen but not in any other organs. The bone marrow was hypercellular with a myeloid: erythroid ratio of approximately 10: 1. Mature, structurally normal eosinophils were the predominant cells. Unlike the eosinophils in the circulation and those seen in the heart and lungs, the bone marrow eosinophils were filled with their characteristic granules. There were no visceral infarcts or other evidence of embolization of the intracardiac mural thrombi. No renal or vascular lesions were observed.
A peptide of approximately 300-400 molecular weight with preferential chemotactic activity for eosinophil PMN leukocytes in vitro was isolated from extracts of the tumor, appeared in the patient's urine and was elaborated by longterm cultures of dispersed tumor cells.11 A comparable eosinophil chemotactic factor was isolated from anaplastic large cell tumors of the lung of two other patients with eosinophilia of the peripheral blood as well as tumor and surrounding tissues, but was absent from a pulmonary adenocarcinoma associated with peripheral blood eosinophilia and a renal cell carcinoma metastatic to the lung which evoked only pulmonary and pleural eosinophilia. The eosinophil chemotactic peptide was approximately the same size as the tetrapeptide of the eosinophil chemotactic factor of anaphylaxis (ECF-A), but was distinctly less acidic." Eosinophils from this patient and one other who exhibited high concentrations of the factor in tumor extracts and urine were hyporesponsive in vitro to their tumor factor and other chemotactic principles, which is functionally consistent with a state of chemotactic deactivation.
Discussion
Although the association of endomyocardial disease and eosinophilia is well documented, 1-7 12-24 the role of the eosinophils in the pathogenesis of the cardiac lesions is obscure. Many authors feel that the eosinophilia is only an associated phenomenon,5' 12-14 while others suggest that the eosinophil itself may be cardiotoxic and have a primary role in causing the endomyocardial lesions." -'7 In our patient, several findings suggest that the cardiac eosinophilia may be associated with cardiotoxicity regardless of the etiology of the eosinophilia. Biochemical studies showed that the pulmonary neoplasm was producing a factor chemotactic for eosinophils.1" Furthermore, the blood eosinophilia was stimulated by and progressed with the course of the tumor in the absence of other diseases known to stimulate eosinophilia, such as collagen-vascular diseases, hypersensitivity states, dermatoses, or parasitic infestations. In addition, since the eosinophilia preceded the clinical cardiac abnormalities, it seems unlikely to have resulted as a reaction to the myocardial damage.
In a study of patients with L6ffler's cardiomyopathy and eosinophilia, Spry and Tai have shown that peripheral blood eosinophils in this disease were vacuolated and degranulated9 as were those of our patient, who also exhibited comparable changes in the eosinophils of the cardiac and pulmonary lesions. The appearance of chemotactic deactivation in serial in vitro studies of the patient's eosinophils" implies that the eosinophil chemotactic peptide or other tumor products initially induced in vivo activation of the eosinophils, possibly including degranulation, which may enhance their ability to lead to tissue damage. Spry suggested that the tissue damage in the heart results from prolonged release of products usually present in eosinophil granules. Archer and Hirsch postulated that enzymes such as hydrolases and peroxidases were released from tissue eosinophils and might play a role in inflammatory reactions and tissue damage. 25 26 The specific localization of eosinophils near the areas of necrosis and fibrosis in the cardiac lesions of patients with endomyocardial disease suggests that they may be mediators of the cardiac damage. Cardiac involvement with clinical signs can occur early in the course of the eosinophilia. In a prospective study of patients with chronic eosinophilia, Borer et al. have shown that echocardiographic abnormalities may be present before the patients develop signs or symptoms of cardiac disease.27 However, the possibility that eosinophils are regulatory cells brought in to confine or control a deleterious tissue response caused by some other unknown factors cannot be excluded.
If the eosinophil acts as a primary mediator of cardiac damage, then therapeutic attempts to reduce the number of eosinophils in patients with endomyocardial disease and eosinophilia might decrease morbidity and mortality from congestive heart failure, arrhythmias and thromboembolic events. In the past, patients with endomyocardial disease and eosinophilia have received steroid therapy with little improvement. 15 and in some the chance of successful resuscitation will be jeopardized. Because information on the energy requirements for defibrillating patients weighing in excess of 150 kg is not available, we report the following pertinent experience.
Case Report A 30-year-old white male with acromegaly for six years and atypical chest pain for two years, noted occasional dizzy spells associated with palpitation. He was on hormonal replacement therapy, and warfarin. He was admitted to the Peter Bent Brigham Hospital for weight reduction prior to cardiac catheterization and coronary angiography.
He was massively obese, weighing 198.5 kg (436.7 lb) and 175 cm (68.9 inches) tall. Skull and acral enlargement was obvious. Pulse rate was 75 beats/min with occasional extrasystoles. Blood pressure was 120/80 mm Hg in the supine position. The cardiac findings were within normal limits. The electrocardiogram showed sinus rhythm at a rate of 56/min with frequent unifocal ventricular premature beats (VPBs). PR interval was 0.18 sec, QRS 0.09 sec and the axis was -30°. There were nonspecific ST and T wave abnormalities. Ambulatory monitoring for 24 hours demonstrated frequent unifocal VPBs, couplets and short runs of 3-5 beat ventricular tachycardia. A posteroanterior chest roentgeno-
